Most cited papers in Angiogenesis and VEGF in Cancer
What are the most cited papers in Angiogenesis and VEGF in Cancer?
The most cited paper in Angiogenesis and VEGF in Cancer is "Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer" (Herbert I. Hurwitz, Louis Fehrenbacher, William F. Novotny et al., 2004), with 11,036 citations. Next come "Tumor Angiogenesis: Therapeutic Implications" (10,238) and "The biology of VEGF and its receptors" (9,633).
Showing 50 of 100 papers. Every paper with more than 2,065 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer Herbert I. Hurwitz, Louis Fehrenbacher, William F. Novotny et al. · New England Journal of Medicine | 2 Jun 2004 | 11,036 |
| 2 | Tumor Angiogenesis: Therapeutic Implications Louis M. Sherwood, Edith E. Parris, Judah Folkman · New England Journal of Medicine | 18 Nov 1971 | 10,238 |
| 3 | The biology of VEGF and its receptors Napoleone Ferrara, Hans‐Peter Gerber, Jennifer E. LeCouter · Nature Medicine | 30 May 2003 | 9,633 |
| 4 | Angiogenesis in cancer and other diseases Peter Carmeliet, Rakesh K. Jain · Nature | Sep 2000 | 9,128 |
| 5 | Isolation of Putative Progenitor Endothelial Cells for Angiogenesis Takayuki Asahara, Toyoaki Murohara, Alison B. Sullivan et al. · Science | 14 Feb 1997 | 8,789 |
| 6 | Angiogenesis in cancer, vascular, rheumatoid and other disease Judah Folkman · Nature Medicine | 1995 | 7,691 |
| 7 | Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis Douglas Hanahan, Judah Folkman · Cell | Aug 1996 | 6,916 |
| 8 | Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer Alan Sandler, Robert J. Gray, Michael C. Perry et al. · New England Journal of Medicine | 13 Dec 2006 | 5,802 |
| 9 | Mechanisms of angiogenesis Werner Risau · Nature | Apr 1997 | 5,752 |
| 10 | Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma Noel Weidner, Joseph P. Semple, William R. W. Welch et al. · New England Journal of Medicine | 3 Jan 1991 | 5,701 |
| 11 | Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy Rakesh K. Jain · Science | 6 Jan 2005 | 5,534 |
| 12 | Molecular mechanisms and clinical applications of angiogenesis Peter Carmeliet, Rakesh K. Jain · Nature | May 2011 | 5,504 |
| 13 | Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen David W. M. Leung, George Cachianes, Wun-Jing Kuang et al. · Science | 8 Dec 1989 | 5,034 |
| 14 | Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis Dorit Shweiki, Ahuva Itin, Dov Soffer et al. · Nature | Oct 1992 | 4,656 |
| 15 | Fibroblasts in cancer Raghu K. Kalluri, Michael Zeisberg · Nature reviews. Cancer | 30 Mar 2006 | 4,547 |
| 16 | Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth Michael S. O’Reilly, Thomas Boehm, Yuen Shing et al. · Cell | 1997 | 4,521 |
| 17 | Angiogenesis in health and disease Peter Carmeliet · Nature Medicine | 30 May 2003 | 4,294 |
| 18 | In silico analysis enabling informed design for genome editing in medicinal cannabis; gene families and variant characterisation Calamita, Elisa, Schmid, Martin, Kunz, Manuel et al. · Figshare | Nov 2019 | 4,236 |
| 19 | Mechanisms of angiogenesis and arteriogenesis Peter Carmeliet · Nature Medicine | Apr 2000 | 4,189 |
| 20 | Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele Peter Carmeliet, Valérie Ferreira, Georg Breier et al. · Nature | Apr 1996 | 4,163 |
| 21 | Activation of Vascular Endothelial Growth Factor Gene Transcription by Hypoxia-Inducible Factor 1 Jo A. Forsythe, Bing‐Hua Jiang, Narayan V. Iyer et al. · Molecular and Cellular Biology | Sep 1996 | 4,003 |
| 22 | Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice Fouad Shalaby, Janet Rossant, Terry P. Yamaguchi et al. · Nature | Jul 1995 | 3,971 |
| 23 | Dissemination and growth of cancer cells in metastatic sites Ann F. Chambers, Alan C. Groom, Ian C. MacDonald · Nature reviews. Cancer | Aug 2002 | 3,963 |
| 24 | Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion Akira Orimo, Piyush B. Gupta, Dennis C. Sgroi et al. · Cell | May 2005 | 3,791 |
| 25 | Angiogenic Factors Judah Folkman, Michael Klagsbrun · Science | 23 Jan 1987 | 3,784 |
| 26 | Vascular Endothelial Growth Factor: Basic Science and Clinical Progress Napoleone Ferrara · Endocrine Reviews | Aug 2004 | 3,722 |
| 27 | Vascular-specific growth factors and blood vessel formation George D. Yancopoulos, Samuel H. Davis, Nicholas W. Gale et al. · Nature | Sep 2000 | 3,706 |
| 28 | Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene Napoleone Ferrara, Karen Carver-Moore, Helen Chen et al. · Nature | Apr 1996 | 3,673 |
| 29 | Circulating Angiogenic Factors and the Risk of Preeclampsia Richard J. Levine, Sharon E. Maynard, Cong Qian et al. · New England Journal of Medicine | 11 Feb 2004 | 3,647 |
| 30 | Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis Peter C. Maisonpierre, Chitra Suri, Pamela F. Jones et al. · Science | 4 Jul 1997 | 3,588 |
| 31 | Tumorigenesis and the angiogenic switch Gabriele Bergers, Laura E. Benjamin · Nature reviews. Cancer | 30 May 2003 | 3,553 |
| 32 | Molecular Regulation of Vascular Smooth Muscle Cell Differentiation in Development and Disease Gary K. Owens, Meena Suresh Kumar, Brian R. Wamhoff · Physiological Reviews | Jul 2004 | 3,526 |
| 33 | Vascular endothelial growth factor (VEGF) and its receptors Gera Neufeld, Tzafra Cohen, Stela Gengrinovitch et al. · The FASEB Journal | 1999 | 3,520 |
| 34 | Angiogenesis in life, disease and medicine Peter Carmeliet · Nature | Dec 2005 | 3,495 |
| 35 | Circulating Endothelial Progenitor Cells, Vascular Function, and Cardiovascular Risk Jonathan Michael Hill, Gloria Zalos, Julian Halcox et al. · New England Journal of Medicine | 12 Feb 2003 | 3,434 |
| 36 | Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma M. OʼReilly · Cell | 21 Oct 1994 | 3,369 |
| 37 | VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche Rosandra Natasha Kaplan et al. · Nature | Dec 2005 | 3,287 |
| 38 | Bone Marrow Origin of Endothelial Progenitor Cells Responsible for Postnatal Vasculogenesis in Physiological and Pathological Neovascularization Takayuki Asahara, Haruchika Masuda, Tomono Takahashi et al. · Circulation Research | 6 Aug 1999 | 3,271 |
| 39 | VEGF receptor signalling ? in control of vascular function Anna‐Karin Olsson, Anna Dimberg, Johan Kreuger et al. · Nature Reviews Molecular Cell Biology | 21 Apr 2006 | 3,138 |
| 40 | Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Harold F. Dvorak, Lawrence F. Brown, Michael J. Detmar et al. · PubMed | May 1995 | 3,129 |
| 41 | Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer Kathy D. Miller, Molin Wang, Julie R. Gralow et al. · New England Journal of Medicine | 26 Dec 2007 | 3,085 |
| 42 | Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis Daniel J. Hicklin, Lee M. Ellis · Journal of Clinical Oncology | 7 Dec 2004 | 3,029 |
| 43 | Requirement of Vascular Integrin α v β 3 for Angiogenesis Peter C. Brooks, Richard A.F. Clark, David A. Cheresh · Science | 22 Apr 1994 | 3,025 |
| 44 | Modes of resistance to anti-angiogenic therapy Gabriele Bergers, Douglas Hanahan · Nature reviews. Cancer | 24 Jul 2008 | 2,965 |
| 45 | VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia Holger Gerhardt, Matthew Golding, Marcus Fruttiger et al. · The Journal of Cell Biology | 16 Jun 2003 | 2,959 |
| 46 | Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis Chitra Suri, Pamela F. Jones, Sybill Patan et al. · Cell | Dec 1996 | 2,867 |
| 47 | A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma Mark R. Gilbert et al. · New England Journal of Medicine | 19 Feb 2014 | 2,855 |
| 48 | Basic and Therapeutic Aspects of Angiogenesis Michael Potente, Holger Gerhardt, Peter Carmeliet · Cell | Sep 2011 | 2,838 |
| 49 | Flow-mediated endothelial mechanotransduction Peter Francis Davies · Physiological Reviews | Jul 1995 | 2,810 |
| 50 | Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis Gabriele Bergers, Rolf A. Brekken, Gerald McMahon et al. · Nature Cell Biology | 20 Sep 2000 | 2,809 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.